Skip to main content
. Author manuscript; available in PMC: 2013 Aug 12.
Published in final edited form as: Curr Opin Clin Nutr Metab Care. 2013 May;16(3):320–327. doi: 10.1097/MCO.0b013e32835e8d80

Table 2.

Biological stress ligands during pregnancy and offspring metabolic function and body composition/risk for overweight

Author Species Prenatal predictor Outcome studied in the offspring Age offspring studied Effect
(a) Animal studies
 Dahlgren et al. [23] Rats Prenatal administration of dexamethasone or IL-6 or TNF-α Adiposity Adulthood All exposures associated with increased body weight and adipose tissue mass
 De Blasio et al. [24] Sheep Maternal glucocorticoid administration during pregnancy Glycemic control Adulthood Hyperinsulinemia
 de Vries et al. [25] Nonhuman primates Maternal dexamethasone administration during pregnancy Glycemic control Young adulthood Impaired glucose tolerance and hyperinsulinemia, with reduced pancreatic b-cell number at 12 months
 Lindsay et al. [26] Rats Glucocorticoid exposure (11β-hydroxysteroid dehydrogenase type 2 inhibitor) Glycemic control Adulthood Hyperglycemia
 Nilsson et al. [27] Rats Maternal exposure to immune challenge during pregnancy Adiposity, food intake, leptin levels, glycemic control Adulthood Associated with increased adipose tissue weights, elevated food intake, increased circulating leptin, reduced insulin sensitivity
Author Prenatal predictor Outcome studied in the offspring Age of offspring Effect
(b) Human studies
 Dalziel et al. [28] Betamethasone administration during pregnancy (randomized–controlled trial) Glucose tolerance Young adulthood Increased insulin resistance
 Fasting et al. [29] Second trimester placental CRH levels Adiponectine and leptin concentrations 3 years No association with leptin; associated with higher concentrations of adiponectin
 Gillman et al. [30] Second trimester placental CRH levels Adiposity 3 years Associated with an overall decrease in body size, but an increase in central adiposity
 Radaelli et al. [31] Maternal IL-6 levels at delivery Body composition Newborns Associated with increased fat mass
 Wadhwa et al. [32] Placental CRH levels at 33 weeks gestation Fetal growth restriction Newborns Associated with higher risk

CRH, corticotrophin-releasing hormone; IL, interleukin; TNF, tumor necrosis factor.